Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3272669 | Journal de Gynécologie Obstétrique et Biologie de la Reproduction | 2013 | 9 Pages |
Abstract
Prolactinoma is the most frequent hormone-secreting pituitary tumor (100Â for million patients) and a major cause of both female and male reproductive function disorders. Physician, gynecologist, urologist and sexologist can face this situation during their career. As part of the fertility restoration, treatment gives very satisfactory results. With adequate management, most women are expected to achieve successful pregnancies. The natural history of these tumors during pregnancy depends on their size with a risk of a clinically relevant estimate between 5Â to 30Â %. Their management is complex, requiring finding balance between effects of pregnancy on tumor growth and potential risks of overtreatment on fetal development. The aim of this study is to discuss the management of prolactinoma on woman before, during and after pregnancy, and to evaluate the medical and surgical alternatives regarding the actual literature.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
I. Fatfouta, J. Delotte, O. Mialon, V. Isnard, A. Bongain,